154 related articles for article (PubMed ID: 2096481)
1. [Hormone substitution in the female climacteric--goals, means, effects].
Hauser GA
Ther Umsch; 1990 Dec; 47(12):970-84. PubMed ID: 2096481
[TBL] [Abstract][Full Text] [Related]
2. [Principles of hormone substitution in the postmenopause period].
Keller PJ
Schweiz Rundsch Med Prax; 1991 Apr; 80(16):431-4. PubMed ID: 2038641
[TBL] [Abstract][Full Text] [Related]
3. [Hormone substitution in menopause].
Keller PJ; Maurer-Major E
Praxis (Bern 1994); 1997 Sep; 86(38):1458-62. PubMed ID: 9381046
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
[TBL] [Abstract][Full Text] [Related]
5. Prognostic features of menopausal and postmenopausal applicants for life insurance.
Schiefeling M
J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
[TBL] [Abstract][Full Text] [Related]
6. Why are physicians reluctant to use estrogens for anything--or do they prefer 'PROFOX'?
Studd J
Menopause Int; 2009 Jun; 15(2):52-4. PubMed ID: 19465668
[TBL] [Abstract][Full Text] [Related]
7. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
8. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses.
Sarrel P; Dobay B; Wiita B
J Reprod Med; 1998 Oct; 43(10):847-56. PubMed ID: 9800666
[TBL] [Abstract][Full Text] [Related]
9. [New forms of estrogenotherapy in postmenopausal osteoporosis].
Meczekalski B; Czyzyk A
Pol Merkur Lekarski; 2009 Jul; 27(157):77-80. PubMed ID: 19650437
[TBL] [Abstract][Full Text] [Related]
10. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
11. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
[TBL] [Abstract][Full Text] [Related]
12. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
L'hermite M; Simoncini T; Fuller S; Genazzani AR
Maturitas; 2008; 60(3-4):185-201. PubMed ID: 18775609
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and progestin supplementation.
Nurse Pract; 1995 Mar; 20(3):63-6. PubMed ID: 7761042
[No Abstract] [Full Text] [Related]
14. [Cancer risk under hormone therapy].
Lauritzen C
Ther Umsch; 1994 Nov; 51(11):755-66. PubMed ID: 7839334
[TBL] [Abstract][Full Text] [Related]
15. [Estrogen-gestagen substitution in geriatric gynecology. Long-term prevention for the third segment of life after menopause].
Lauritzen C
Fortschr Med; 1996 May; 114(15):187-90. PubMed ID: 8767936
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of transdermal with oral hormone substitution: a multicenter study with a new matrix patch].
Sajtos B; Herold J; Winkler UH; Schindler AE
Zentralbl Gynakol; 1995; 117(10):524-30. PubMed ID: 7491835
[TBL] [Abstract][Full Text] [Related]
17. Pulsed estrogen therapy: relieving climacteric symptoms, preventing postmenopausal bone loss.
Palacios S
Climacteric; 2002 Jun; 5 Suppl 2():32-9. PubMed ID: 12482109
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
Burger H
Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
[TBL] [Abstract][Full Text] [Related]
19. Current trends in hormone replacement therapy.
Khashoggi TY
Saudi Med J; 2002 May; 23(5):495-502. PubMed ID: 12070567
[TBL] [Abstract][Full Text] [Related]
20. Risks and benefits of long-term treatment with estrogens.
Mack TM; Ross RK
Schweiz Med Wochenschr; 1989 Dec; 119(50):1811-20. PubMed ID: 2692147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
